News

Western Midstream Unveils Pathfinder Pipeline and Future Growth

Western Midstream Unveils Pathfinder Pipeline and Future Growth

Western Midstream Announces Major Infrastructure Developments

Today, Western Midstream Partners, LP (NYSE: WES) revealed exciting plans to enhance its operations with the new Pathfinder pipeline. This advanced project is designed to support the transportation of over 800 MBbls/d of produced water to existing and new facilities. This strategic expansion aims to improve operational efficiency while addressing the increasing demands of produced water disposal in the industry.

Pathfinder Pipeline Project Overview

The Pathfinder pipeline is a groundbreaking 42-mile, 30-inch steel pipeline that promises to revolutionize how water is handled in eastern regions. By relocating produced water from high-activity areas, WES intends to maximize disposal capacity, streamline logistics, and lay a foundation for future growth opportunities. This initiative cements WES’s commitment to delivering innovative solutions in the rapidly evolving midstream sector.

Key Collaborations and Contracts

In collaboration with Occidental Petroleum Corporation, Western Midstream has executed a new long-term produced-water agreement. This partnership will facilitate up to 280 MBbls/d of comprehensive gathering and transportation services, supplemented by an additional 220 MBbls/d of firm disposal capacity. Both companies aim to bolster their operational efficiencies and sustainability practices while meeting the evolving needs of their clients.

Robust Financial Guidance for 2025

WES is optimistic about its financial trajectory, providing 2025 Adjusted EBITDA guidance in the range of $2.350 billion to $2.550 billion. This demonstrates a projected 5 percent increase compared to the previous year. Moreover, the anticipated capital expenditures for 2025 are estimated between $625 million and $775 million, supporting the ongoing development of the Pathfinder project and overall system expansion.

Distributions and Growth Prospects

As part of its commitment to enhancing shareholder value, WES plans to propose a Base Distribution increase to $0.910 per unit, reflecting a 13 percent rise compared to prior distributions paid in 2024. This strategic approach aims to target a mid-to-low single-digit annual growth rate in distributions, catering to both organic growth initiatives and potential acquisition strategies.

Investments in Infrastructure

Over the next two years, Western Midstream plans to invest approximately $400 million to $450 million into the construction of critical produced-water infrastructure. This includes the Pathfinder pipeline and additional gathering facilities and disposal terminals across pivotal regions featuring incremental capacities of 280 MBbls/d.

Future of Produced Water Management

Western Midstream's proactive measures in expanding its produced-water management system underline its commitment to sustainable practices. By prioritizing organic growth projects and effective capital allocation strategies, the company is positioned well to handle future production demands and become a key player in the midstream market.

Executive Insights

Oscar Brown, President and CEO of Western Midstream, expressed enthusiasm about the Pathfinder project's potential. "Through our extensive experience and strategic partnerships, we are poised to deliver a sustainable and innovative disposal solution in the Delaware Basin," he stated. Brown emphasized the strategic significance of leveraging existing infrastructure to facilitate growth and meet client needs effectively.

Kristen Shults, Senior Vice President and CFO, echoed Brown’s sentiments and highlighted WES's resilient financial outlook. "We expect continued growth from our core operations, and we are dedicated to optimizing profitability through innovative solutions and efficient operations. The commitment to increasing our distributions underscores our focus on returning value to our stakeholders," she concluded.

About Western Midstream Partners

Western Midstream Partners, LP is a prominent player in the midstream asset space, dedicated to developing, acquiring, owning, and managing essential infrastructure. With assets in diverse regions, WES specializes in natural gas processing, crude oil transportation, and produced-water disposal. Its considerable cash flows are predominantly shielded from volatile commodity prices, ensuring stability and predictability in revenues.

Frequently Asked Questions

What is the Pathfinder pipeline project?

The Pathfinder pipeline is a new 42-mile infrastructure designed to transport produced water efficiently and sustainably in the Delaware Basin.

How will Western Midstream's 2025 guidance affect its stakeholders?

The 2025 guidance indicates a strong financial outlook for WES, projecting significant increases in Adjusted EBITDA and distributions for stakeholders.

What partnerships has Western Midstream established?

Western Midstream has formed a long-term agreement with Occidental Petroleum to enhance its water gathering and disposal capabilities.

What are the expansion plans beyond the Pathfinder project?

WES plans to invest in additional gathering and disposal facilities to support operational growth and meet rising production levels across its service areas.

What strategies is Western Midstream employing for future growth?

Western Midstream is focusing on organic growth projects, efficient capital allocation, and strategic partnerships to drive sustainable development.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 278

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 187

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 131

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

New Insights on Targeting Toxic Gain of Function Mutations

Updated Category News Views 137

Understanding Toxic Gain of Function Mutations San Diego-based n-Lorem Foundation has made significant strides in the field of rare genetic disorders. They recently released findings in the journal Nucleic Acid Therapeutics, focusing on treatment strategies for patients with heterozygous toxic gain-of-function (TGOF) mutations. This publication aims to shed light on...

Continue Reading
Allogenica Secures Funding for Revolutionary CAR-T Innovations

Updated Category News Views 289

Allogenica Secures Significant Grant for CAR-T Therapy Development Allogenica has received a substantial €2.5 million grant from a government initiative to boost the industrialization of its pioneering universal CAR-T therapies specifically designed for blood cancers. This funding aims to facilitate the transition of their innovative treatments from the lab to the...

Continue Reading
Health Data Analytics Institute Enhances Patient Care with AI

Updated Category News Views 141

Health Data Analytics Institute Transforms Cancer Care with AI Health Data Analytics Institute (HDAI) is shaping the future of healthcare through their innovative collaboration with a renowned cancer center. This partnership is focused on enhancing goal-concordant care, which is crucial for patients facing serious illnesses. By implementing cutting-edge protocols, HDAI...

Continue Reading
SPEED TONNEAU SYSTEM: The New Game-Changer in Convertible Design?

Updated Category News Views 166

PITTSBURGH, Feb. 17, 2026—InventHelp's latest development, the SPEED TONNEAU SYSTEM, is stirring up chatter among automotive enthusiasts and potential investors alike. This invention comes from an inventor in South Holland, Illinois, who wanted to tackle a common issue with convertible cars: visibility and aesthetics when the top is down. In short? It’s all about that...

Continue Reading
SenesTech Secures $4.4 Million through Warrant Exercise

Updated Category News Views 168

SenesTech's Warrant Exercise Generates Significant Funds SenesTech, Inc. (NASDAQ: SNES), renowned for its innovative solutions in fertility control aimed at managing animal pest populations, has successfully closed the exercise of certain outstanding warrants. This exercise has generated approximately $4.4 million in gross proceeds, significantly boosting the company's...

Continue Reading